Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients

Recently, the combination of chemotherapy plus nivolumab (chemo-immunotherapy) has become the standard of care for advanced-stage gastric cancer (GC) patients. However, despite its efficacy, up to 40% of patients do not respond to these treatments. Our study sought to identify variations in gene exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Mauricio P., Muñoz-Medel, Matías, Retamal, Ignacio N., Bravo, MariaLoreto, Latapiat, Verónica, Córdova-Delgado, Miguel, Hill, Charlotte N., Fernández, M. Fernanda, Sánchez, Carolina, Sáez, Mauricio A., Martin, Alberto J. M., Morales-Pison, Sebastián, Fernandez-Ramires, Ricardo, García-Bloj, Benjamín, Owen, Gareth I., Garrido, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820415/
https://www.ncbi.nlm.nih.gov/pubmed/36613445
http://dx.doi.org/10.3390/ijms24010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820415/
https://www.ncbi.nlm.nih.gov/pubmed/36613445
http://dx.doi.org/10.3390/ijms24010001

Ejemplares similares